These results highlight the significance of ApoA1 and ApoB plasma levels and their ratio in early diagnosis and risk stratification of premature CAD by indicating that they are better predictors of pCAD risk than conventional plasma lipoprotein measures. The gene discussed is APOA1; the disease is coronary artery disorder.